dc.contributor.author | Jones, Robin Lewis | en |
dc.contributor.author | Constantinidou, Anastasia | en |
dc.contributor.author | Reis-Filho, J. S. | en |
dc.creator | Jones, Robin Lewis | en |
dc.creator | Constantinidou, Anastasia | en |
dc.creator | Reis-Filho, J. S. | en |
dc.date.accessioned | 2018-06-22T09:53:42Z | |
dc.date.available | 2018-06-22T09:53:42Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41980 | |
dc.description.abstract | This article reviews the conceptual and practical implications of the intrinsic subtype classification of breast cancers and the limitations of this approach. It presents the most extensively validated gene expression assays proposed as predictors of clinical outcome and discusses their potential clinical utility and limitations. © 2012. | en |
dc.language.iso | eng | en |
dc.source | Surgical Pathology Clinics | en |
dc.subject | Breast cancer | en |
dc.subject | Basal-like | en |
dc.subject | Claudin-low | en |
dc.subject | Her2-enriched | en |
dc.subject | Luminal types | en |
dc.subject | Molecular pathology | en |
dc.subject | Normal breast-like | en |
dc.subject | Prognostic markers | en |
dc.title | Molecular Classification of Breast Cancer | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1016/j.path.2012.06.008 | |
dc.description.volume | 5 | |
dc.description.issue | 3 | |
dc.description.startingpage | 701 | |
dc.description.endingpage | 717 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Constantinidou, Anastasia [0000-0001-5316-7574] | |
dc.gnosis.orcid | 0000-0001-5316-7574 | |